Exotic and Emerging Avian Viral Diseases Research Unit Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
Avian Influenza
Asian Bird Flu
Newcastle Disease
 

Research Project: INTERVENTION STRATEGIES TO CONTROL NEWCASTLE DISEASE

Location: Exotic and Emerging Avian Viral Diseases Research Unit

Title: Complete genome sequence and clinicopathological characterization of a virulent Newcastle disease virus isolated from poultry in South America

Authors
item Diel, Diego
item Susta, Leonardo -
item Cardenas Garcia, Stivalis -
item Killian, Mary Lea -
item Brown, Corrie -
item Miller, Patti
item Afonso, Claudio

Submitted to: Meeting Abstract
Publication Type: Abstract Only
Publication Acceptance Date: November 2, 2011
Publication Date: January 26, 2012
Citation: Diel, D.G., Susta, L., Cardenas Garcia, S., Killian, M., Brown, C., Miller, P.J., Afonso, C.L. 2012. Complete genome sequence and clinicopathological characterization of a virulent Newcastle disease virus isolated from poultry in South America. Meeting Abstract. Vol.50, pages 378-387.

Technical Abstract: Newcastle disease (ND) is one of the most important diseases of poultry, negatively affecting poultry production worldwide. The disease is caused by Newcastle disease virus (NDV) or avian paramyxovirus type-1 (APMV-1), a negative sense single-stranded RNA virus of the genus Avulavirus, family Paramyxoviridae. Although all NDV isolates characterized to date belong to a single serotype of APMV-1, significant genetic diversity has been described between different NDV isolates. Here, we present the complete genome sequence and the clinicopathological characterization of a virulent Newcastle disease virus isolate (NDV-Peru/08) obtained from poultry during an outbreak of ND in Peru in 2008. Phylogenetic reconstruction based on the complete genome sequence demonstrated that NDV-Peru/08 is clearly distinct from viruses of other known NDV genotypes. Analysis of the evolutionary distances between NDV-Peru/08 and isolates representing established NDV genotypes revealed the existence of large genomic and amino differences that distinguish this isolate from viruses of typical NDV genotypes. Although NDV-Peru/08 is a genetically distinct virus, pathogenesis studies conducted in chickens revealed that NDV-Peru/08-infection results in clinical signs characteristic of velogenic viscerotropic NDV strains. Additionally, vaccination studies have shown that an inactivated NDV-LaSota/46 vaccine conferred full protection from NDV-Peru/08-induced clinical disease and mortality. Characterization of novel NDV isolates that occasionally emerge and cause outbreaks or of those that frequently circulate worldwide are important to improve the current understanding of NDV epidemiology and evolution, and for the development of improved control and diagnostic strategies.

   

 
Project Team
Afonso, Claudio
Suarez, David
Miller, Patti
 
Publications
   Publications
 
Related National Programs
  Animal Health (103)
 
Related Projects
   NEWCASTLE DISEASE VACCINE EVALUATION
   RECOMBINANT NEWCASTLE DISEASE VACCINES: RISK FOR RECOMBINATION, REVERSION TO VIRULENCE AND SPREAD IN NON-TARGET SPECIES
   EVALUATION OF NEWCASTLE DISEASE VIRUS VACCINES AGAINST CIRCULATING VIRUSES
   PATHOGENESIS OF SELECTED NEWCASTLE DISEASE VIRUS FIELD ISOLATES AND RECOMBINANTS
   IMPROVEMENT OF NEWCASTLE DISEASE VIRUS VACCINES FOR AFRICA
   DEVELOPMENT OF CANARYPOX BASED VACCINES
   DEVELOPMENT OF CANARYPOX BASED VACCINES AGAINST MEXICAN VIRULENT NEWCASTLE DISEASE AND AVIAN INFLUENZA VIRUSES
   FOLLOW-ON: REDUCING DISEASE IN LIVESTOCK
   PATHOGENIC CHARACTERIZATION NEWCASTLE DISEASE VIRUS FIELD ISOLATES
   Pathogenic Characterization Newcastle Disease Virus Field Isolates
 
 
Last Modified: 05/21/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House